Three Years of AdvanSci Research Solutions

AdvanSci Research Consulting

As AdvanSci Research Solutions celebrated its third birthday on January 27th, we’re taking a moment to reflect on our journey and celebrate the milestones that have shaped our company since 2022. What began as two PhD graduates’ vision to improve the quality of biomedical research has grown into a thriving service provider supporting researchers in Sweden and beyond.

Growing Our Team and Expertise

In 2020, our co-founders, Jane Fisher and Daniela Grassi, launched AdvanSci Research Consulting, a consortium of independent consultants driven by a mission to simplify good research practices for researchers. Over the next two years, the demand for their services increased steadily, and in 2022, AdvanSci Research Consulting became AdvanSci Research Solutions AB.

Since then, AdvanSci has expanded to a team of 4 dedicated professionals, all holding PhDs in life sciences. Our team includes experienced medical writers, research consultants, and project managers with over 45 years of combined expertise in the field. We’ve also cultivated a strong network of specialized subcontractors in statistics, medical writing, and regulatory affairs.

Supporting Groundbreaking Research

Over the past three years, we’ve had the privilege of contributing to numerous important research initiatives, helping our clients secure over 105 million SEK to fund their scientific studies.

Clinical Trials and Initiatives

Some of our most impactful work over the last 3 years was in the field of clinical studies. We’re particularly proud that our grant writing service helped secure funding from Vetenskapsrådet for three significant clinical trials:

  • The GLUSORB study, testing an innovative cytokine filtration treatment for lung transplantation (19 500 000 SEK from Vetenskapsrådet in 2022)
  • The REDUSE trial, aiming to optimize fluid administration in septic shock patients (19 291 860 SEK from Vetenskapsrådet in 2023)
  • The PROPER trial, examining methods to reduce postoperative atrial fibrillation in cardiac surgery patients (17 741 200 SEK from Vetenskapsrådet in 2024)

We have also helped secure major funding for The Bridge – Lungs for Life project (~18 million SEK from Interreg), a cross-border Danish-Swedish collaboration aimed at establishing Europe’s first centralized facility for revitalizing damaged donor lungs for transplantation.

We have also had the opportunity to work directly with several exciting clinical studies via our clinical trial management and planning services, including the REDUSE and GLUSORB trials mentioned above. We feel privileged to be able to work with such diverse clinical initiatives and are excited to follow their results and see their real impact on human health in the coming years.

Publications and other scientific communication

Our commitment to good research practices and clear and transparent communication is exemplified in the numerous publications to which we have contributed over the last 3 years. In this time we have:

  • Written more than 15 scientific manuscripts and several conference abstracts via our scientific/medical writing service, covering diverse fields such as urology, dermatology and transplantation
  • Prepared visual content, via our scientific illustration service, including graphs and figures to support research findings for several scientific manuscripts, grant applications, and conference presentations
  • Provided English-language editing of several peer-reviewed publications in fields ranging from infection medicine to sustainability

Regulatory Documentation

Our work doesn’t end when a study is funded or a manuscript is published. We also support our clients during their entire journey while they work to bring their innovative new treatments to the market. We have provided writing and editing services for various regulatory documents, including:

  • Clinical evaluation documentation for CE marking of medical devices
  • Clinical investigation applications for medical devices
  • Documentation for orphan drug designation applications
  • Documentation for scientific advice (EMA) and pre-IND (FDA)

Recognition and Achievements

Our commitment to improving science has got people taking notice! We have been recognized through several notable achievements:

  • Selection of our co-founders for the Rapidus 34orna list in 2022, highlighting promising young companies in Skåne
  • Recognition in Företagarna’s ”103 unga idéer 2024,” celebrating innovative young entrepreneurs
  • Graduation from Ideon’s BUILD program, where we refined our vision for a web application to guide biomedical researchers
  • Participation in the Life Science Academy for Startups program, which provides professional support while we expand our business model and market strategy

Community Engagement

Our mission to spread good research practices extends beyond the services that we provide to our clients, leading us to engage with the scientific community through various initiatives:

  • Founding and supporting the Lund Biomedicine ReproducibiliTea journal club
  • Organizing workshops on reducing scientific and statistical bias across Sweden and Denmark
  • Participating in networks and events at Medicon Village
  • Presenting at the Medicon Village Career Day in 2024
  • Presenting the ways that our services and other community engagement initiatives can help advance Open Science at the 2024 LU Open Science Days event
  • Providing educational content ranging from writing tips to information about best research practices on our LinkedIn page, which just welcomed its 1200th follower!

Looking Forward

As we enter our fourth year as a company, we remain committed to our mission of improving the quality of biomedical research and developing innovative solutions and services that make good research practices more accessible to scientists worldwide.

We extend our heartfelt appreciation to our clients, partners, and the broader scientific community for their trust and support over the past three years. Your collaboration has been instrumental in our growth and success.

Here’s to many more years of advancing science together!

About AdvanSci Research Solutions

Founded in 2022, AdvanSci provides scientific advice, medical writing and editing, and study management services to help researchers ensure their work meets the highest standards of quality and reproducibility.